A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Public ClinicalTrials.gov record NCT06339008. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to 29.5 months.
Study identification
- NCT ID
- NCT06339008
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 25, 2024
- Primary completion
- Aug 31, 2026
- Completion
- Sep 30, 2028
- Last update posted
- Aug 23, 2026
2024 – 2028
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allergy and Asthma Specialists Medical Group | Huntington Beach | California | 92648 | — |
| 310 Clinical Research | Inglewood | California | 90301 | — |
| Allergy & Asthma Associates of Southern California dba. Southern California Research | Laguna Niguel | California | 92677 | — |
| Allergy and Asthma | San Diego | California | 92123 | — |
| Asthma and Allergy Associates, PC | Colorado Springs | Colorado | 80907-6231 | — |
| Allergy and Asthma Diagnostic Center | Tallahassee | Florida | 32308 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Asthma Allergy Center of Chicago | River Forest | Illinois | 60305 | — |
| Bluegrass Allergy Research | Lexington | Kentucky | 40509 | — |
| Respiratory Medicine Research Institute of Michigan, PLC | Ypsilanti | Michigan | 48197 | — |
| Clinical Research Institute | Minneapolis | Minnesota | 55402 | — |
| University of Missouri Hospital | Columbia | Missouri | 65212 | — |
| Allergy and Asthma Consultants | St Louis | Missouri | 63141 | — |
| Asthma and Allergy Center | Bellevue | Nebraska | 68123 | — |
| Circuit Clinical/Hudson-Essex Allergy | Belleville | New Jersey | 07109 | — |
| Circuit Clinical/Mercer Allergy and Pulmonary Associates | Hamilton | New Jersey | 08619 | — |
| Dr. Patrick Perin | Teaneck | New Jersey | 07666 | — |
| Smith Allergy and Asthma | Horseheads | New York | 14845 | — |
| Allergy Partners | Asheville | North Carolina | 28803 | — |
| Bernstein Clinical Research Center, LLC | Cincinnati | Ohio | 45236 | — |
| Northwest Research Center | Portland | Oregon | 97202 | — |
| Allergy and Clinical Immunology Associates | Pittsburgh | Pennsylvania | 15241 | — |
| AARA Research Center | Dallas | Texas | 75231 | — |
| Kerrville Allergy and Asthma Associates | Kerrville | Texas | 78028 | — |
| Allergy, Asthma & Sinus Center | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06339008, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06339008 live on ClinicalTrials.gov.